Annual award recognizes outstanding Breakthrough T1D volunteer leadership
Houston and New York, Feb. 12, 2025—Breakthrough T1D, formerly JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, proudly announces Jordan Amis as the recipient of the 2024 Carol and Erwin Lurie Award for her robust volunteerism, leadership in fundraising events, outreach to newly diagnosed families, and service as on the Board of Directors and as a Stewardship Ambassador.
Named after Carol and Erwin Lurie, who helped found Breakthrough T1D in 1970, the Carol and Erwin Lurie Award is presented to a chapter volunteer whose commitment to the volunteer and staff partnership has significantly advanced the mission and strategic priorities of Breakthrough T1D over the past fiscal year.
Jordan became involved with Breakthrough T1D in 2009 after her son, Charlie, was diagnosed with T1D. Since then, she has served Breakthrough T1D locally and nationally in a variety of meaningful capacities. Jordan currently serves on the Houston Board of Directors as the president-elect and as a member of the Executive Committee. As the chair of the Southern Texas Chapter’s gala in 2024, she helped the event raise $2.8 million and directly impacted the event’s total revenue by $348,000 through host committees, auction items, and table spends. Jordan has been recognized as one of Houston’s top five fundraisers for the Breakthrough T1D Walk, chaired Breakthrough T1D Community Summits, helped organize regional gatherings for those affected by T1D, and shared her family’s T1D journey to help mobilize individuals to join the fight against the disease. At the national level, she has provided her expertise to the Breakthrough T1D Global Mission Board’s Stewardship Initiative Pilot and represented the organization in Washington, D.C. for the walk pilot program and Children’s Congress.
“Breakthrough T1D is proud to present Jordan Amis with this well-deserved award and recognize her ongoing dedication to spreading awareness of type 1 diabetes, raising funds for critical research, and building community support that will drive us to cures faster,” said Aaron Kowalski, PhD, Breakthrough T1D CEO. “Jordan’s efforts are an inspiration to the type 1 diabetes community, and we appreciate her commitment to moving our mission forward.”
Breakthrough T1D recognizes and appreciates all of the dedicated volunteers and supporters who commit their lives to the worldwide effort to end T1D. Volunteer award recipients were recognized at the annual Breakthrough T1D One Conference in Phoenix, Arizona.
About Breakthrough T1D, Formerly JDRF
As the leading global type 1 diabetes research and advocacy organization, Breakthrough T1D helps make everyday life with type 1 diabetes better while driving toward cures. We do this by investing in the most promising research, advocating for progress by working with government to address issues that impact the T1D community, and helping educate and empower individuals facing this condition.
About Type 1 Diabetes (T1D)
T1D is an autoimmune condition that causes the pancreas to make very little insulin or none at all. This leads to dependence on insulin therapy and the risk of short and long-term complications, which can include highs and lows in blood sugar; damage to the kidneys, eyes, nerves, and heart; and even death. Globally, it impacts nearly 9 million people. Many believe T1D is only diagnosed in childhood and adolescence, but diagnosis in adulthood is common and accounts for nearly 50% of all T1D diagnoses. The onset of T1D has nothing to do with diet or lifestyle. While its causes are not yet entirely understood, scientists believe that both genetic factors and environmental triggers are involved. There is currently no cure for T1D.
###
